Natan Ledderman
Tel Aviv, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Familial Mediterranean fever in patients with inflammatory bowel diseases: a nationwide study from the epi-IIRN.
Journal: Rheumatology (Oxford, England)
Published: March 15, 2024
Peripheral Blood Eosinophilia at Diagnosis of Inflammatory Bowel Disease Is Associated With Severe Disease Course: A Nationwide Study From the epi-IIRN Cohort.
Journal: Journal of Crohn's & colitis
Published: December 02, 2023
The Epidemiology of Inflammatory Bowel Diseases During the COVID-19 Pandemic: Comparison of Two Nationwide Cohorts.
Journal: Journal of Crohn's & colitis
Published: November 22, 2023
Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN.
Journal: Inflammatory bowel diseases
Published: October 27, 2023
Predictors of Complicated Disease Course in Adults and Children With Crohn's Disease: A Nationwide Study from the epi-IIRN.
Journal: Inflammatory bowel diseases
Published: October 21, 2023
Inflammatory bowel disease among first generation immigrants in Israel: A nationwide epi-Israeli Inflammatory Bowel Disease Research Nucleus study.
Journal: World journal of methodology
Published: September 13, 2023
Durability of the First Biologic in Patients with Crohn's Disease: A Nationwide Study from the epi-IIRN.
Journal: Journal of Crohn's & colitis
Published: July 19, 2023
Thiopurines Have Longer Treatment Durability than Methotrexate in Adults and Children with Crohn's Disease: A Nationwide Analysis from the epi-IIRN Cohort.
Journal: Journal of Crohn's & colitis
Published: April 26, 2023
Association of Antibiotic Use with Durability of Biologic Agents in Inflammatory Bowel Disease: a Report from the epi-IIRN.
Journal: Journal of Crohn's & colitis
Published: April 21, 2023
Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN Cohort.
Journal: Inflammatory bowel diseases
Published: March 03, 2023
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN.
Journal: Inflammatory bowel diseases
Published: January 10, 2023
5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort study.
Journal: Alimentary pharmacology & therapeutics
Published: October 23, 2022
Last Updated: 09/26/2026